258 results on '"Petrone, Linda"'
Search Results
2. Booster dose of SARS-CoV-2 messenger RNA vaccines strengthens the specific immune response of patients with rheumatoid arthritis: A prospective multicenter longitudinal study
3. Accuracy of QuantiFERON SARS-CoV-2 research use only assay and characterization of the CD4+ and CD8+ T cell-SARS-CoV-2 response: comparison with a homemade interferon-γ release assay
4. Humoral and cellular responses to spike of δ SARS-CoV-2 variant in vaccinated patients with immune-mediated inflammatory diseases
5. Persistent Spike-specific T cell immunity despite antibody reduction after 3 months from SARS-CoV-2 BNT162b2-mRNA vaccine
6. Coinfection of tuberculosis and COVID-19 limits the ability to in vitro respond to SARS-CoV-2
7. The potential clinical utility of measuring severe acute respiratory syndrome coronavirus 2-specific T-cell responses
8. Spike is the most recognized antigen in the whole-blood platform in both acute and convalescent COVID-19 patients
9. Expression and production of the SERPING1-encoded endogenous complement regulator C1-inhibitor in multiple cohorts of tuberculosis patients
10. Alternative biomarkers of tuberculosis infection in patients with immune-mediated inflammatory diseases
11. Immune Therapy, or Antiviral Therapy, or Both for COVID-19: A Systematic Review
12. Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection
13. IP-10 contributes to the inhibition of mycobacterial growth in an ex vivo whole blood assay
14. First description of agonist and antagonist IP-10 in urine of patients with active TB
15. Evaluation of IP-10 in Quantiferon-Plus as biomarker for the diagnosis of latent tuberculosis infection
16. The Importance of Measuring SARS-CoV-2-Specific T-Cell Responses in an Ongoing Pandemic
17. Antigen discovery by bioinformatics analysis and peptide microarray for the diagnosis of cystic echinococcosis
18. Severe chest allodynia as an unusual first presentation of hydatid disease: a case report
19. Use of several immunological markers to model the probability of active tuberculosis
20. A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients
21. Longitudinal characterisation of B and T-cell immune responses after the booster dose of COVID-19 mRNA-vaccine in people with multiple sclerosis using different disease-modifying therapies
22. Identification of HLA-E Binding Mycobacterium tuberculosis–Derived Epitopes through Improved Prediction Models
23. Evaluation of the immunomodulatory effects of interleukin-10 on peripheral blood immune cells of COVID-19 patients: Implication for COVID-19 therapy
24. Coordinated innate and T-cell immune responses in mild COVID-19 patients from household contacts of COVID-19 cases during the first pandemic wave
25. Longitudinal characterisation of B and T-cell immune responses after the booster dose of COVID-19 mRNA-vaccine in people with multiple sclerosis using different disease-modifying therapies.
26. Clinical isolates of the modern Mycobacterium tuberculosis lineage 4 evade host defense in human macrophages through eluding IL-1β-induced autophagy
27. Humoral and Cellular Response to Spike of Delta SARS-CoV-2 Variant in Vaccinated Patients With Multiple Sclerosis
28. Platelets accumulate in lung lesions of tuberculosis patients and inhibit T‐cell responses and Mycobacterium tuberculosis replication in macrophages
29. Kinetics of the B- and T-Cell Immune Responses After 6 Months From SARS-CoV-2 mRNA Vaccination in Patients With Rheumatoid Arthritis
30. Immune-Guided Therapy of COVID-19
31. Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy
32. World Tuberculosis Day 2021 Theme — ‘The Clock is Ticking’ — and the world is running out of time to deliver the United Nations General Assembly commitments to End TB due to the COVID-19 pandemic
33. The definition of tuberculosis infection based on the spectrum of tuberculosis disease
34. Accuracy of an experimental whole-blood test for detecting reactivation of echinococcal cysts
35. Mycobacterium tuberculosis Immune Response in Patients With Immune-Mediated Inflammatory Disease
36. Antibody Subclass and Glycosylation Shift Following Effective TB Treatment
37. In Vitro Models for Studying Entry, Tissue Tropism, and Therapeutic Approaches of Highly Pathogenic Coronaviruses
38. Transglutaminase 2 Regulates Innate Immunity by Modulating the STING/TBK1/IRF3 Axis
39. In-vitro evaluation of the immunomodulatory effects of Baricitinib: Implication for COVID-19 therapy
40. Epidemic and pandemic viral infections: impact on tuberculosis and the lung
41. Systematic review on tuberculosis risk in patients with rheumatoid arthritis receiving inhibitors of Janus Kinases
42. Species specificity preliminary evaluation of an IL‐4‐based test for the differential diagnosis of human echinococcosis
43. Inhibition of Transglutaminase 2 as a Potential Host-Directed Therapy Against Mycobacterium tuberculosis
44. QuantiFERON TB Gold Plus for the diagnosis of tuberculosis: a systematic review and meta-analysis
45. Heat Shock Proteins and Autoimmunity in Patients with Carotid Atherosclerosis
46. Free Hemoglobin: A Dangerous Signal for the Immune System in Patients with Carotid Atherosclerosis?
47. Humoral- and T-Cell–Specific Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients With MS Using Different Disease-Modifying Therapies
48. Risk of tuberculosis reactivation associated with traditional disease modifying anti-rheumatic drugs and non-anti-tumor necrosis factor biologics in patients with rheumatic disorders and suggestion for clinical practice
49. Recombinant HPV16 E7 assembled into particles induces an immune response and specific tumour protection administered without adjuvant in an animal model
50. Complement Component C1q as Serum Biomarker to Detect Active Tuberculosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.